Medtronic (MDT) Tops Q1 EPS by 6c, Beats on Revenue; Offers FY27 EPS Guidance
Tweet
Share
E-mail
Get Alerts MDT Hot Sheet
Price: $92.13 -0.69%
Revenue Growth %: +5.3%
Financial Fact:
Net sales: 4.32B
Today's EPS Names:
VIVO, OCCI, ALZN, More
Revenue Growth %: +5.3%
Financial Fact:
Net sales: 4.32B
Today's EPS Names:
VIVO, OCCI, ALZN, More
Join SI Premium – FREE
Medtronic (NYSE: MDT) reported Q1 EPS of $1.45, $0.06 better than the analyst estimate of $1.39. Revenue for the quarter came in at $9.8 billion versus the consensus estimate of $9.55 billion.
GUIDANCE:
Medtronic sees FY2027 EPS of $5.94-$6.00, versus the consensus of $5.95.
For earnings history and earnings-related data on Medtronic (MDT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- U.S. and Denmark close in on a Greenland deal - Reuters
- RBC Capital Reiterates Sector Perform Rating on Freehold Royalties Ltd. (FRU:CN) (FRHLF)
- Anthropic delays planned IPO from October to November - WSJ
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
